Neurologia medico-chirurgica · 2011 · 25 citations · 12 references
MedicineNeurosurgerySurgeryNeuro-oncologyOncologic SurgerySurgical OncologyNeuro-oncologic SurgerySubarachnoid HemorrhageSubdural HematomaChronic Subdural HematomaColon Cancer SurgeryNeuroendoscopic InstrumentationNeuroendoscopic SurgerySubdural DrainageSubdural Hematoma Clinical PresentationSurgical Evacuation Of Hematoma
A 78-year-old Japanese man with a history of colon cancer was referred to our department of neurosurgery for the management of asymptomatic left chronic subdural hematoma (CSDH). He was receiving bevacizumab therapy for colon cancer, and the size of the CSDH increased or decreased depending on bevacizumab administration. Simple drainage was performed because of the risk of a critical increase in the size of CSDH during bevacizumab therapy, but since the CSDH was organized and firm, the drainage was insufficient. Therefore, neuroendoscope-assisted craniotomy was performed, and the organized CSDH was almost completely removed. The present case indicates the possible involvement of bevacizumab in the occurrence of CSDH and the efficacy of the neuroendoscopic approach in the surgical treatment of organized CSDH.
12
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Alan Sandler, Robert J. Gray, Michael C. Perry et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text
Medicine, Oncology, Pharmacology +13
Fairooz F. Kabbinavar, Herbert I. Hurwitz, Louis Fehrenbacher et al. · Journal of Clinical Oncology · 2002 · 1.7K citations
Medicine, Oncology, Pharmacotherapy +13
Safety of anticoagulation use and bevacizumab in patients with glioma
Phioanh L. Nghiemphu, Richard M. Green, Whitney B. Pope et al. · Neuro-Oncology · 2008 · 92 citations · Full text